compare insulin glargine
edema
severe hypoglycemia
tingle in the hand
concomitant medication
therapeutic protein
update communication
runny nose
n rrb
possible increase risk of cancer
other factor
rapid improvement in glucose control
insulin glargine
rash
cold sweat
sore throat
cancer occurrence
incidence for all hypoglycemia
ongoing safety review
risk
weakness
drowsiness
standard care
vomit
foot
irregular heartbeat
cool pale skin
nausea
swell of the eyelid
february
skin rash
underlie disease
overall incidence of all type of cancer
hive
restless sleep
slurred speech
weight gain
upper
cramp
early type diabetes mellitus
sodium retention
sensitivity
rhinitis
fast pulse
specificity of the assay
swell at the injection site
dysgeusiafrequency
standard care group
nightmare
pruritus at the injection site
urticaria
inflammation
cv risk factor
depression of the skin at the injection site
increase thirst
be
abnormal glucose level
confusion
dizziness or lightheadedness
lipodystrophy
hand
active ingredient
improve
risk of cancer
presence of insulin antibody
numbness
respiratory infection
hypoglycemia
fda in a
swell of the face
insulin
tongue
origin
excessive hunger
median change in body weight from baseline
blur vision
impaired fasting glucose
metabolic control
convulsion seizure
headachevery
cv
sweating
cough
eye
adolescent
unusual tiredness
pruritus
long term glycemic control
retinopathy
first occurrence of a major adverse cardiovascular event
puffiness
standard group
rapid weight gain
potential for immunogenicity exit
we fda
incidence of mace
pharyngitis
decrease in glucosuria
erythema
gastroenteritis
child
july
difficulty with thinking
chill
case
use of this insulin
anxiety
bloat
rash urticaria
myalgia
n
efficacy of insulin
reversible acute painful peripheral neuropathy
thicken of the skin at injection site
headache
nervousness
insulin glargine group
local edema
hypoglycemiafrequency
evidence
hypertension
anaphylaxis
peripheral neuropathy
detection of antibody formation
muscle pain
cleanse agent
redness
worsen of diabetic retinopathy
itch over the entire body
trouble breathing
difficulty with swallow
outcome reduction with initial glargine intervention
sinusitis
peripheral edema
basaglar
lip
sample handling
reversible ophthalmologic refraction disorder
dry mouth
irritant in skin
decrease urine
pain
itch
swell
collection
lipohypertrophyuncommon
mace
antibody formation
fast heartbeat
impaired glucose tolerance
behavior change
kg
disease
fever
face
shakiness
injection site pain
lower leg
visual impairment
assay methodology
adult